Arena Pharmaceuticals, Yext, IAC, and more


Arena Pharmaceuticals Inc.: “We like Arena. We’ve liked it. I know it’s speculative. It’s O.K. for a spec, as long as you’re willing to understand that this is not Merck. “

IAC/InterActiveCorp.: “I thought that was an amazing quarter. I think that company is so inexpensive, I frankly don’t even understand it. I say it’s a buy, buy, buy.”

Yext inc.: “I like Y-E-X-T … I think the stock is a buy.”

Davita Inc.: “Why didn’t you just go into Abbott Labs? I mean honestly, Davita is way too volatile for me. I don’t know. Let it rally a little … but no, we don’t want Davita.”

Chemours Co.: “From the day it was spun off I didn’t like it. It had a nice little rally, it’s come back down. I don’t like it.”

WATCH: Cramer’s lightning round

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer’s world? Hit him up!
Jim Cramer TwitterFacebookInstagram

Questions, comments, suggestions for the “Mad Money” website?

Source link

Products You May Like

Articles You May Like

Chipmaker stocks plunge on report they are dropping business with Huawei
Beyond Meat hype is ‘beyond stupid’
Coolest and weirdest things, from robots to air taxis
3 steps to determine whether you’ve earned the right to invest
Boeing NMA 797 launch likely delayed after 737 Max crisis